EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.3.1.255 | F128I | site-directed mutagenesis, the mutation leads an altered structure and reduced stability, and a dramatic recuction of Nt catalytic activity compared to wild-type | Homo sapiens |
2.3.1.255 | F128L | site-directed mutagenesis, the mutation leads an altered structure and reduced stability, and a dramatic recuction of Nt catalytic activity compared to wild-type | Homo sapiens |
2.3.1.255 | additional information | enzyme knockdown by siRNA. Generation of mutant daf-31(m655) by removal of 151 bp of promoter upstream of the ATG start codon and 242 bp of daf-31 coding region dowstream of the ATG start codon. Generation of and overexpression mutant daf-31 OE for which the full-length dar-31 genomic DNA is cloned into pGEM-T vector. Generation of mutant vncBDk by with impaired N-terminal activity | Caenorhabditis elegans |
2.3.1.255 | additional information | generation of an Ard1 null mutant by removal of the ARD1 coding region | Trypanosoma brucei |
2.3.1.255 | additional information | generation of enzyme mutant by frame shift mutation causing a acetyltransferase-truncated enzymatic region, and of another mutant vnc by intron-insertion mutation | Drosophila melanogaster |
2.3.1.255 | additional information | generation of mutant naa10-1 and of a naa15 mutant by T-DNA insertion-disrupting gene expression | Arabidopsis thaliana |
2.3.1.255 | additional information | generation of mutant naa10MO by morpholino-based knockdown | Danio rerio |
2.3.1.255 | additional information | mutation ard1::HIS3 is caused by inserting a Barn HI fragment containinng the HIS3 gene into the Barn HI site of plasmid YCpE18 that lies within the functional sequence of ARD1. Genes nat1/ard1 double mutant nat1-5::LEU;ard1 is generated by mating of nat1 and ard1 single mutants, the single mutants of nat1 (Naa15) and ard1 (Naa10) display identical phenotypes, no additional phenotypes are found in the double mutant. Recombinant expression of the S37P mutant of human Naa10 in a NatA-defective yeast strain, the hNaa10 expressing mutant strain shows a lack of proper complex formation with hNaa15 and reduced in vitro catalytic activity, a decrease of Nt-acetylome and an increase in the Hsp70 family proteins | Saccharomyces cerevisiae |
2.3.1.255 | R116W | site-directed mutagenesis, the mutation leads to a reduction in catalytic activity for the peptide substrates EEEI and SESS by 15% compared to wild-type | Homo sapiens |
2.3.1.255 | R83C | site-directed mutagenesis, the mutation interferes with acetyl-CoA binding and leads to a 60% reduction in Nt-catalytic activity compared to wild-type | Homo sapiens |
2.3.1.255 | S37P | site-directed mutagenesis, the mutant Naa10 protein shows reduced catalytic activity for EEEI, DDDI, and SESS peptide substrates, and inability to combine with Naa15. The mutant hNaa10 S37P recombinantly expressed in a NatA-defective Saccharomyces cerevisiae strain lacks a proper complex formation with hNaa15 and is reduced in in vitro catalytic activity | Homo sapiens |
2.3.1.255 | S39P | site-directed mutagenesis, the mutation does not cause a phenotype | Saccharomyces cerevisiae |
2.3.1.255 | V107F | site-directed mutagenesis, the mutation leads to a reduction in catalytic activity for the peptide substrates EEEI and SESS by 95% compared to wild-type | Homo sapiens |
2.3.1.255 | Y43S | site-directed mutagenesis, the mutant is catalytically impaired in vitro, with approximately an 85% reduction in Nt-catalytic activity for peptide substrates EEEI, DDDI, and SESS | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.3.1.255 | Arabidopsis thaliana | Q9FKI4 | - |
- |
2.3.1.255 | Caenorhabditis elegans | O61219 | - |
- |
2.3.1.255 | Caenorhabditis elegans DAF-31 | O61219 | - |
- |
2.3.1.255 | Danio rerio | Q7T3B8 | - |
- |
2.3.1.255 | Drosophila melanogaster | Q9VT75 | - |
- |
2.3.1.255 | Homo sapiens | P41227 | - |
- |
2.3.1.255 | Mus musculus | Q3UX61 | - |
- |
2.3.1.255 | Mus musculus | Q9QY36 | - |
- |
2.3.1.255 | Mus musculus C57Bl6/J | Q3UX61 | - |
- |
2.3.1.255 | Mus musculus C57Bl6/J | Q9QY36 | - |
- |
2.3.1.255 | Saccharomyces cerevisiae | P07347 AND P12945 | subunits Naa10 and Naa15 of enzmye complex NatA | - |
2.3.1.255 | Saccharomyces cerevisiae ATCC 204508 | P07347 AND P12945 | subunits Naa10 and Naa15 of enzmye complex NatA | - |
2.3.1.255 | Trypanosoma brucei | Q9NFL8 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.3.1.255 | bone | - |
Mus musculus | - |
2.3.1.255 | brain | during brain development in mouse, Naa10 and Naa15 (the auxiliary subunit of NatA) are highly expressed in regions rich in proliferating and migrating cells, such as the ventricular zone, neocortex, olfactory bulb, and hippocampus. The expression of both genes is downregulated as neurons differentiate and mitotic and migratory activities subside. Then, once again, their expression increases during postnatal development in the hippocampus and during the neuronal dendritic development of Purkinje cells (PCs) in the cerebellum. This finding indicates that the regulation of expression of both genes is related to neuronal development, especially in the hippocampus and in the PCs of the cerebellum | Mus musculus | - |
2.3.1.255 | cerebellar Purkinje cell | - |
Mus musculus | - |
2.3.1.255 | colon | - |
Homo sapiens | - |
2.3.1.255 | colon | - |
Mus musculus | - |
2.3.1.255 | hippocampus | - |
Mus musculus | - |
2.3.1.255 | kidney | - |
Homo sapiens | - |
2.3.1.255 | kidney | - |
Mus musculus | - |
2.3.1.255 | liver | - |
Homo sapiens | - |
2.3.1.255 | liver | - |
Mus musculus | - |
2.3.1.255 | lung | - |
Homo sapiens | - |
2.3.1.255 | lung | - |
Mus musculus | - |
2.3.1.255 | additional information | NAA10 and NAA11 display opposite expression patterns during spermatogenesis. No expression of Naa11 in premeiotic spermatogonia | Mus musculus | - |
2.3.1.255 | additional information | tissue-specific expression of Naa10 during different developmental stages in C57BL6/J mice | Mus musculus | - |
2.3.1.255 | additional information | tissue-specific expression of Naa10 during different developmental stages in humans | Homo sapiens | - |
2.3.1.255 | NB-4 cell | NAA10 expression decreases with the induction of differentiation in NB4 cells, but the level of NAA11 remains unchanged | Mus musculus | - |
2.3.1.255 | neuron | - |
Mus musculus | - |
2.3.1.255 | occipital lobe | - |
Homo sapiens | - |
2.3.1.255 | occipital lobe | - |
Mus musculus | - |
2.3.1.255 | olfactory bulb | - |
Mus musculus | - |
2.3.1.255 | osteoblast | - |
Mus musculus | - |
2.3.1.255 | parietal lobe | - |
Homo sapiens | - |
2.3.1.255 | parietal lobe | - |
Mus musculus | - |
2.3.1.255 | skin | - |
Homo sapiens | - |
2.3.1.255 | skin | - |
Mus musculus | - |
2.3.1.255 | spermatogonium | Naa10 is expressed in premeiotic spermatogonia | Mus musculus | - |
2.3.1.255 | spinal cord | - |
Homo sapiens | - |
2.3.1.255 | spinal cord | - |
Mus musculus | - |
2.3.1.255 | testis | NAA11, a homologue of NAA10, is predominantly expressed in mouse testis | Mus musculus | - |
2.3.1.255 | testis | NAA11, a homologue of NAA10, is predominantly expressed in mouse testis. NAA10 and NAA11 display opposite expression patterns during spermatogenesis | Mus musculus | - |
2.3.1.255 | tongue | - |
Homo sapiens | - |
2.3.1.255 | tongue | - |
Mus musculus | - |
2.3.1.255 | uterus | - |
Homo sapiens | - |
2.3.1.255 | uterus | - |
Mus musculus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.255 | acetyl-CoA + N-terminal L-aspartyl-[DDIAALRWGRPVGRRRRPVRVYP] | - |
Homo sapiens | CoA + H+ + N-terminal Nalpha-acetyl-L-aspartyl-[DDDIAALRWGRPVGRRRRPVRVYP] | - |
? | |
2.3.1.255 | acetyl-CoA + N-terminal L-glutamyl-[EEIAALRWGRPVGRRRRPVRVYP] | - |
Homo sapiens | CoA + H+ + N-terminal Nalpha-acetyl-L-glutamyl-[EEEIAALRWGRPVGRRRRPVRVYP] | - |
? | |
2.3.1.255 | acetyl-CoA + N-terminal L-methionyl-[LGPEGGRWGRPVGRRRRPVRVYP] | - |
Homo sapiens | CoA + H+ + N-terminal Nalpha-acetyl-L-methionyl-[MLGPEGGRWGRPVGRRRRPVRVYP] | - |
? | |
2.3.1.255 | acetyl-CoA + N-terminal L-seryl-[ESSSKSRWGRPVGRRRRPVRVYP] | - |
Homo sapiens | CoA + H+ + N-terminal Nalpha-acetyl-L-seryl-[SESSSKSRWGRPVGRRRRPVRVYP] | - |
? | |
2.3.1.255 | additional information | acetylation of alpha-tubulin | Mus musculus | ? | - |
- |
|
2.3.1.255 | additional information | enzyme zNaa10 has a predicted N-terminal activity with identical substrate specificity to human Naa10 in vitro | Danio rerio | ? | - |
- |
|
2.3.1.255 | additional information | acetylation of alpha-tubulin | Mus musculus C57Bl6/J | ? | - |
- |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.3.1.255 | ARD1 | - |
Danio rerio |
2.3.1.255 | ARD1 | - |
Trypanosoma brucei |
2.3.1.255 | ARD1 | - |
Drosophila melanogaster |
2.3.1.255 | ARD1 | - |
Saccharomyces cerevisiae |
2.3.1.255 | Ard1b | - |
Mus musculus |
2.3.1.255 | ARD2 | - |
Mus musculus |
2.3.1.255 | AtNAA10 | - |
Arabidopsis thaliana |
2.3.1.255 | daf-31 | - |
Caenorhabditis elegans |
2.3.1.255 | N-alpha-acetyltransferase | - |
Caenorhabditis elegans |
2.3.1.255 | N-alpha-acetyltransferase 10 | - |
Homo sapiens |
2.3.1.255 | N-alpha-acetyltransferase 10 | - |
Danio rerio |
2.3.1.255 | N-alpha-acetyltransferase 10 | - |
Mus musculus |
2.3.1.255 | N-alpha-acetyltransferase 10 | - |
Arabidopsis thaliana |
2.3.1.255 | N-alpha-acetyltransferase 11 | - |
Mus musculus |
2.3.1.255 | NAA10 | - |
Homo sapiens |
2.3.1.255 | NAA10 | - |
Danio rerio |
2.3.1.255 | NAA10 | - |
Mus musculus |
2.3.1.255 | NAA10 | - |
Arabidopsis thaliana |
2.3.1.255 | NAA11 | - |
Mus musculus |
2.3.1.255 | NAT1 | - |
Saccharomyces cerevisiae |
2.3.1.255 | TbARD1 | - |
Trypanosoma brucei |
2.3.1.255 | vnc | - |
Caenorhabditis elegans |
2.3.1.255 | yNaa10 | - |
Saccharomyces cerevisiae |
2.3.1.255 | yNaa15 | - |
Saccharomyces cerevisiae |
2.3.1.255 | zNaa10 | - |
Danio rerio |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
2.3.1.255 | acetyl-CoA | - |
Homo sapiens |
EC Number | Organism | Comment | Expression |
---|---|---|---|
2.3.1.255 | Mus musculus | in mouse, the expression of Naa10 is downregulated during meiosis | down |
2.3.1.255 | Mus musculus | in mouse, the expression of Naa11 is upregulated during meiosis | up |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.3.1.255 | malfunction | enzyme knockdown causes a phenotype with lethality, growth retardation, bent axis and tails, abnormal eyes, and less pigmentation | Danio rerio |
2.3.1.255 | malfunction | enzyme mutants show phenotypes with pleiotropic oogenesis, aberrant mitosis, egg chamber encapsulation defects, and nurse cell chromatin dispersion defects | Drosophila melanogaster |
2.3.1.255 | malfunction | inactive Naa10 mutant S37Pw shows a phenotype with perinatal lethal disorder, hypotonia, global developmental delay, cryptorchidism, cardiac arrhythmias, skin laxity, dysmorphic features, hernias, and large fontanels. Naa10 mutant Y43S shows a phenotype with intellectual disability, facial dysmorphism, scoliosis, and long QT. Mutant R83C shows a phenootype with hypotonia, global developmental delay, dysmorphic features, autism spectrum disorder, epileptic encephalopathy, extrapyramidal signs, hypertension with left ventricular hypertrophy, thin corpus callosum, and progressive white matter loss. Mutations V107F and R116W cause phenotypes with severe global developmental delay with postnatal growth, skeletal anomalies, truncal hypotonia with hypertonia of the extremities, minor facial features, and behavioral anomalies. Mutation of residue F128 causes moderate to severe intellectually disability, feeding difficulties, eye anomalies, hypotonia, and developmental delay | Homo sapiens |
2.3.1.255 | malfunction | mutation ard1::HIS3 leads to a defect in transcription of a-specific genes, but permits expression of the information resident at HML. The mutant shows a phenotypes with reduced viability and sensitivity to heat shock and salt, it fails to enter stationay phase, it shows a lack of glycogen accumulation, a sporulation defect, poor mating, and fails to undergo meiosis. The mutant nat1-5::LEU;ard1 is inable to sporulate, has slow growth, reduced mating, inhibited sporulation, and impaired resistance to heat shock. It fails G1 arrest, shows a partial depression of HML, and fails to accumulate storage. yNaa10 deficiency leads to a growth defect, sensitivity to caffeine and cycloheximide, impaired resistance to heat shock, and decreased mating efficiency | Saccharomyces cerevisiae |
2.3.1.255 | malfunction | overexpression of gene daf-31 causes an increased lifespan in daf-2 mutant enhancing reproduction, while daf-31 knockdown by siRNA causes a decreased lifespan | Caenorhabditis elegans |
2.3.1.255 | malfunction | overexpression of Naa10 in mice results in the delayed closure of calvarial fontanels and reduced bone density, osteoblast surfaces and mRNA levels of the osteoblastogenic genes in calvaria. In contrast, Naa10 deficient mice display calvarial and femoral bone development to a greater extent on postnatal day 3 | Mus musculus |
2.3.1.255 | malfunction | the ARD1 null mutation leads to impaired growth in bloodstream-form cells and reduced differentiation to insect-stage cells | Trypanosoma brucei |
2.3.1.255 | malfunction | the naa10 knockout mutant naa10-1 shows growth retardation in vegetative stage, abortion of embryogenesis, and drought-adapted root morphology, the mutation is lethal. A knockout of naa15 causes the same phenotype | Arabidopsis thaliana |
2.3.1.255 | physiological function | enzyme Daf-31 regulates the transcriptional activity of DAF-16, the FOXO transcription factor. Mutant daf-31(m655) leads to developmental larval arrest, fat accumulation, formation of dauer-like larvae under starvation conditions, and decreased lifespan, and the mutant lacks SDS-resistance and cannot resume development and reproduction after food re-providing | Caenorhabditis elegans |
2.3.1.255 | physiological function | importance of NAA10 catalytic activity in human development. The potential role of NAA10 varies depending on transcriptional levels in different tissues and embryonic stages during development | Homo sapiens |
2.3.1.255 | physiological function | importance of NAA10 catalytic activity in mouse development. The potential role of NAA10 varies depending on transcriptional levels in different tissues and embryonic stages during development. Naa10 homologue Naa11 has a role in the cellular differentiation process while Naa10 has a role in the cellular proliferation process. The differential expression pattern of Naa10 and Naa11 suggests that Naa11 is complementary to Naa10 at least in the mice and that its biological role can be important in spermiogenesis or cellular processes | Mus musculus |
2.3.1.255 | physiological function | importance of NAA10 catalytic activity in mouse development. The potential role of NAA10 varies depending on transcriptional levels in different tissues and embryonic stages during development. Naa10 homologue Naa11 has a role in the cellular differentiation process while Naa10 has a role in the cellular proliferation process. The differential expression pattern of Naa10 and Naa11 suggests that Naa11 is complementary to Naa10 at least in the mice and that its biological role can be important in spermiogenesis or cellular processes. Naa10 is known to regulate cellular processes, and its effects are not only catalyzed through its major activity as a NAT but also through the N-epsilon-acetylation of several proteins. The N-epsilon-acetyl-activity of Naa10 requires auto-acetylation. This requirement is similar to that of other acetyltransferases, which acetylate themselves for their catalytic and functional activities. Naa10 plays an important role in osteoblast differentiation and the early phases of bone formation. Naa10 counteracts HDAC6 by acetylating alpha-tubulin, thereby promoting MT stability for dendritic development | Mus musculus |
2.3.1.255 | physiological function | Naa10 is crucial for cell growth and sporulation | Saccharomyces cerevisiae |